Home
Home » companies

AstraZeneca

AstraZeneca Steady After Patent Setback

AstraZeneca Steady After Patent Setback
Motley Fool

Who's the Frailest Big Pharma of All?

Who's the Frailest Big Pharma of All?
Motley Fool

How Serious Is This News for Diabetes Drugmakers?

How Serious Is This News for Diabetes Drugmakers?
Motley Fool

It's Time for This Big Pharma to Save Its Future

It's Time for This Big Pharma to Save Its Future
Motley Fool

Atherosclerosis and the New Gold Standard

Atherosclerosis and the New Gold Standard
Yahoo/Accesswired

AstraZeneca Inks Deal

AstraZeneca Inks Deal
Yahoo/Zacks

Shire to Forest on Deal List for AstraZeneca: Real M&A

Shire to Forest on Deal List for AstraZeneca: Real M&A
Bloomberg

What Will Type 2 Diabetes Treatments Look Like in 5 Years?

What Will Type 2 Diabetes Treatments Look Like in 5 Years?
Motley Fool

AstraZeneca Forecasts Lower Profit Amid Generic Pressure

AstraZeneca Forecasts Lower Profit Amid Generic Pressure
Bloomberg

AstraZeneca, Bristol-Myers’s Forxiga Not Backed by NICE

AstraZeneca, Bristol-Myers’s Forxiga Not Backed by NICE
Bloomberg